< Return to Video

CRITICAL THINKING - Cognitive Biases: Reference Dependence and Loss Aversion [HD]

  • 0:00 - 0:06
    (intro music)
  • 0:06 - 0:07
    My name is Laurie Santos.
  • 0:07 - 0:11
    I teach psychology at Yale University,
    and today I want to talk to you about
  • 0:11 - 0:14
    reference dependence and loss aversion.
  • 0:14 - 0:17
    This lecture is part of a
    series on cognitive biases.
  • 0:17 - 0:21
    Imagine that you're a doctor heading a
    medical team that's trying to fight a new
  • 0:21 - 0:26
    strain of deadly flu, one that's currently
    spreading at an alarming rate.
  • 0:26 - 0:30
    The new flu is so devastating that six
    hundred million people have already
  • 0:30 - 0:34
    been infected, and if nothing
    is done, all of them will die.
  • 0:34 - 0:39
    The good news is there are two, drugs
    available to treat the disease and your
  • 0:39 - 0:42
    team can decide which one
    to put into mass production.
  • 0:42 - 0:47
    Clinical trials show that if you go with
    the first drug, drug A, you'll be able to
  • 0:47 - 0:50
    save two hundred million
    of the infected people.
  • 0:50 - 0:52
    The second option is drug B, which has a
  • 0:52 - 0:56
    one-third chance of saving all six hundred
    million people, but a two-thirds
  • 0:56 - 0:59
    chance that no one infected will be saved.
  • 0:59 - 1:00
    Which drug do you pick?
  • 1:00 - 1:04
    You probably thought drug
    A was the best one.
  • 1:04 - 1:08
    After all, with drug A, two hundred
    million people will be saved for sure,
  • 1:08 - 1:10
    which is a pretty good outcome.
  • 1:10 - 1:13
    But now imagine that your team is faced
    with a slightly different choice.
  • 1:13 - 1:16
    This time, it's between drug C and drug D.
  • 1:16 - 1:20
    If you choose drug C, four
    hundred million infected
  • 1:20 - 1:21
    people will die for sure.
  • 1:21 - 1:24
    If you choose drug D, there's a one-third chance
  • 1:24 - 1:28
    that no one infected will die, and a
    two-thirds chance that six hundred million
  • 1:28 - 1:30
    infected people will die.
  • 1:30 - 1:32
    Which drug do you choose in this case?
  • 1:32 - 1:35
    I bet you probably wen with drug D.
  • 1:35 - 1:39
    After all, a chance that no one will
    die seems like a pretty good bet.
  • 1:39 - 1:41
    If you picked drug A in the first scenario
  • 1:41 - 1:44
    and drug D in the second, you're not alone.
  • 1:44 - 1:46
    When behavioral economists Danny Kahneman
  • 1:46 - 1:48
    and Amos Tversky gave these
    scenarios to college students,
  • 1:48 - 1:52
    seventy-two percent of people said
    that drug A was better than B,
  • 1:52 - 1:56
    and seventy-eight percent of people
    said that drug D was better than C.
  • 1:56 - 2:01
    But let's take a slightly different
    look at both sets of outcomes.
  • 2:01 - 2:04
    In fact, let's depicted both choices in
  • 2:04 - 2:07
    terms of the number of people
    who will live and die.
  • 2:07 - 2:09
    Here's your first choice.
  • 2:09 - 2:13
    Drug A will save two hundred million
    people for sure, and for drug B, there's a
  • 2:13 - 2:17
    one-third chance that all six hundred million
    infected people will be saved and a
  • 2:17 - 2:20
    two-thirds chance that no
    one infected will be saved.
  • 2:20 - 2:24
    And now, let's do the same
    thing for drugs C and D.
  • 2:24 - 2:29
    Surprisingly, you can now see
    that the two options are identical.
  • 2:29 - 2:33
    Drugs A and C will save two hundred
    million people, while four hundred million
  • 2:33 - 2:34
    people are certain to die.
  • 2:34 - 2:38
    And with both drug B and drug D, you
    have a one-third chance of saving all
  • 2:38 - 2:42
    six hundred million people and a
    two-thirds chance of saving no one.
  • 2:42 - 2:46
    We can argue about whether it's better to
    save two hundred million people for sure,
  • 2:46 - 2:49
    or to take a one-third chance
    of saving all of them.
  • 2:49 - 2:51
    But one thing should be clear from
  • 2:51 - 2:56
    the example: it's pretty weird for you to
    prefer drug A over B at the same time as
  • 2:56 - 2:58
    you prefer drug D over C.
  • 2:58 - 3:03
    After all, they're exactly the same drugs
    with slightly different labels.
  • 3:03 - 3:05
    Why does a simple change
    in wording change our
  • 3:05 - 3:08
    judgments about exactly the same options?
  • 3:08 - 3:13
    Kahneman and Tversky figured out that this
    strange effect results from two classic
  • 3:13 - 3:15
    biases that affect human choice,
  • 3:15 - 3:18
    biases known as "reference
    dependence" and "loss aversion."
  • 3:18 - 3:22
    "Reference dependence" just refers the
    fact that we think about our decisions
  • 3:22 - 3:27
    not in terms of absolutes, but relative
    to some status quo or baseline.
  • 3:27 - 3:29
    This is why, when you find
    a dollar on the ground,
  • 3:29 - 3:33
    you don't think about that dollar
    as part of your entire net worth.
  • 3:33 - 3:36
    Instead, you think in terms
    of the change that the dollar
  • 3:36 - 3:37
    made your status quo.
  • 3:37 - 3:40
    You think, "Hey, I'm one dollar richer!"
  • 3:40 - 3:44
    because of reference dependence, you
    don't think of the options presented earlier
  • 3:44 - 3:46
    in terms of the absolute number of lives saved.
  • 3:46 - 3:50
    Instead, you frame each choice
    relative to some status quo.
  • 3:50 - 3:53
    And that's why the wording matters.
  • 3:53 - 3:55
    The first scenario is described in terms
  • 3:55 - 3:56
    of the number of life saved.
  • 3:56 - 3:58
    That's your reference point.
  • 3:58 - 4:02
    You're thinking in terms of how many
    additional lives you can save.
  • 4:02 - 4:04
    And in the second, you think relative
  • 4:04 - 4:07
    to how many less lives you can lose.
  • 4:07 - 4:10
    And that second part, worrying about losing
  • 4:10 - 4:15
    lives, leads to the second bias that's
    affecting your choices: loss aversion.
  • 4:15 - 4:20
    Loss aversion is our reluctance to
    make choices that lead to losses.
  • 4:20 - 4:24
    We don't like losing stuff, whether
    it's money, or lives, or even candy.
  • 4:24 - 4:28
    We have an instinct to avoid
    potential losses at all costs.
  • 4:28 - 4:32
    Economists have found that
    loss aversion causes us to do
  • 4:32 - 4:33
    a bunch of irrational stuff.
  • 4:33 - 4:37
    Loss aversion causes people to
    hold onto property that's losing in
  • 4:37 - 4:39
    value in the housing market, just because
  • 4:39 - 4:42
    they don't want to sell
    their assets at a loss.
  • 4:42 - 4:47
    Loss aversion also leads people to
    invest more poorly, even avoid risky
  • 4:47 - 4:49
    stocks that overall will do well, because
  • 4:49 - 4:53
    we're afraid of a small probability of losses.
  • 4:53 - 4:55
    Loss aversion causes to latch onto the
  • 4:55 - 4:59
    fact that drugs C and D involve losing lives.
  • 4:59 - 5:02
    Our aversion to any potential losses causes
  • 5:02 - 5:05
    us to avoid drug C and to go with drug D,
  • 5:05 - 5:08
    which is the chance of not losing anyone.
  • 5:08 - 5:10
    Our loss aversion isn't as activated
  • 5:10 - 5:12
    when we hear about drugs A and B.
  • 5:12 - 5:17
    Both of them involve saving people,
    so why not go with the safe option,
  • 5:17 - 5:19
    drug A over drug B?
  • 5:19 - 5:22
    Merely describing the outcomes differently
  • 5:22 - 5:25
    changes which scenarios
    we find more aversive.
  • 5:25 - 5:27
    If losses are mentioned, we want to
  • 5:27 - 5:29
    reduce them as much as possible,
  • 5:29 - 5:33
    so much so, that we take on a bit
    more risk than we usually like
  • 5:33 - 5:37
    So describing the decision one
    way, as opposed to another,
  • 5:37 - 5:39
    can cause us to make a
    completely different choice.
  • 5:39 - 5:41
    even in a life-or-death decision
  • 5:41 - 5:45
    like this, we're at the mercy of our
    minds interpret information.
  • 5:45 - 5:50
    And how our minds interpret information
    is at the mercy of our cognitive biases.
Title:
CRITICAL THINKING - Cognitive Biases: Reference Dependence and Loss Aversion [HD]
Description:

Laurie Santos, a psychologist at Yale University, explains two of our classic economic biases: reference dependence and loss aversion. Using a classic scenario from Kahneman and Tversky’s studies, she explores how these two biases violate economic rationality and how they affect the choices we make every day.

more » « less
Video Language:
English
Duration:
05:58

English subtitles

Revisions